Brief: Aptevo Therapeutics Sells Ixinity Hemophilia B Therapy For Estimated Proceeds In Excess Of $100 Million

Medexus Pharmaceuticals

28/02/2020 14:23

Feb 28 (Reuters) - Aptevo Therapeutics Inc  APVO.O :
    * APTEVO THERAPEUTICS SELLS IXINITY HEMOPHILIA B THERAPY FOR
ESTIMATED PROCEEDS IN EXCESS OF $100 MILLION
    * APTEVO THERAPEUTICS - UNDER TERMS, MEDEXUS ACQUIRED
WORLDWIDE
COMMERCIAL RIGHTS TO IXINITY

Source text: (http://bit.ly/2I6mnjT)
Further company coverage:  APVO.O 

 ((Reuters.Briefs@thomsonreuters.com;))